Results for 'NCI'
MSL Talk: Tom Caravela, Steven Stein
How and Why MSLs Bring VALUE to an Organization
MSL role, KOL engagement, drug development process, enhancing medical affairs, strategic direction MSL
In this episode, Steven Stein, senior director of global field medical at Arena Pharmaceuticals, joins the discussion to explore the evolving role of MSLs. He delves into the concept of value within the MSL role and the strategic timing for their involvement in the drug development process. Ste…
Dec 14th • 31 mins listen
MSL Talk: Tom Caravela, Norwood Harris
Career Longevity: What behavioral competencies will help you have career longevity and stability
Norwood Harris, MSL career development, networking in MSL roles, managing performance reviews, career longevity in pharma
In this episode, Norwood Harris shares his extensive experience and career journey at Sandoz and Novartis, providing insights into career longevity and navigating mergers within large and small companies. He emphasizes the importance of networking and building strong internal relationships, alo…
Oct 6th • 37 mins listen
MSL Talk: Tom Caravela, Stephanie Otis
The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges
MSL trends, skills for MSLs, digital literacy in healthcare, future-proof MSL career, patient-centric MSLs
This week’s guest is Stephanie Otis, Vice President Global Medical Excellence at Ferring Pharmaceuticals discusses future trends in the MSL field including the skills and competencies that will be essential for success. Key Points Scientific acumen, storytelling, and relationship-buildin…
Oct 22nd • 35 mins listen
MSL Talk: Tom Caravela, Stephanie Otis
The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges
MSL skills, future trends, digital literacy, AI in healthcare, patient-centricity
This week’s guest is Stephanie Otis, Vice President Global Medical Excellence at Ferring Pharmaceuticals discusses future trends in the MSL field including the skills and competencies that will be essential for success. Key Points Scientific acumen, storytelling, and relationship-buildin…
Oct 22nd • 35 mins listen
Cancer Buzz Podcast
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
Asco Daily News Podcast
Enhancing Treatment Efficacy in Multiple Myeloma at ASCO24
Drs. John Sweetenham and Marc Braunstein discuss practice-changing studies in hematologic malignancies that were featured at the 2024 ASCO Annual Meeting, including the ASC4FIRST trial in chronic myeloid leukemia and IMROZ and CARTITUDE-4 in multiple myeloma.
Jun 24th • 23 mins listen
The Oncology Nursing Podcast
Industry Challenges Contribute to Financial Toxicity
In this third panel discussion from ONS’s Health Policy Summit in Washington DC, Alan Balch, PhD, Patient Advocate Foundation chief executive officer, Mike Ybarra, MD, FAAEM, FACEP, vice president of medical affairs for the Pharmaceutical Research Manufacturers Association, and Jeannine…
Feb 18th • 66 mins listen
The Oncology Nursing Podcast
CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation
“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…
May 24th • 40 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen
Cancer Buzz Podcast
Clinical Trial Access in Rural Areas
Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …
Oct 16th • 24 mins listen
The Oncology Nursing Podcast
The Practical Side of Clinical Trials
ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS’s Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, han…
Sep 18th • 39 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen
The Oncology Nursing Podcast
How Biosimilars Could Impact the Future of Cancer Care
Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what bio…
May 7th • 16 mins listen
The Oncology Nursing Podcast
Biosimilar Basics for Oncology Nurses and Patients
“The way I approach patient education conversations is to discuss it, address it, but not to emphasize it. I really like to focus on what the drug is. I mention if it’s a biosimilar, I explain it, I give resources if they want it, but I really try to focus on the things that they&rsquo…
Feb 1st • 30 mins listen
The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
CDER, FDA, Nurses, biomarker, immunomodulatory
Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…
Mar 30th • 53 mins listen